Leveraging Bicycle® Molecules as Radio-Imaging & Theranostics Agents

• Understanding Bicycle® Molecules: Contrasting discovery and PK/PD profiles compared to ADCs
• Assessing commonly used imaging techniques and understanding links to PK profiles
• Delving into Gallium-68 PET imaging with Bicycle® Molecules as predictors of target engagement

Speakers:

Arnaud Tiberghien,

Head, Chemistry & Platform Technology Science,

Bicycle Therapeutics plc